COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and 50mg Administered Orally Once Daily, in Adults With Rheumatoid Arthritis
1 other identifier
interventional
2,208
33 countries
341
Brief Summary
This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jun 2005
Shorter than P25 for phase_3
341 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
June 7, 2005
CompletedFirst Posted
Study publicly available on registry
June 8, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2006
CompletedMarch 14, 2017
March 1, 2017
1.3 years
June 7, 2005
March 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of American College of Rheumatology (ACR)20 Responders at Week 12
Week 12
Secondary Outcomes (32)
Change from baseline to each scheduled visit in tender/painful joint count (68 joint panel)
Baseline and Week 12
Change from baseline to each scheduled visit in swollen joint count (66 joint panel)
Baseline and Week 12
Change from baseline to each scheduled visit in patient's pain assessment (VAS)
Baseline and Week 12
Change from baseline to each scheduled visit in physician's global assessment of arthritis condition
Baseline and Week 12
Change from baseline to each scheduled visit in patient's global assessment of arthritis condition
Baseline and Week 12
- +27 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Rheumatoid arthritis (RA) for at least 12 months.
- Required a non-steroidal anti-inflammatory drug (NSAID) or COX-2 inhibitor for RA for at least 5 out of 7 days of each week for the 4 weeks prior to screening.
You may not qualify if:
- Any history of cardiovascular disease (e.g., heart attack, stroke, congestive heart failure, uncontrolled high blood pressure), documented peripheral arterial insufficiency and symptomatic, clinically significant claudication, or who have a history of peripheral arterial embolism.
- Have an active stomach ulcer or history of any stomach tear or bleeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
Study Sites (341)
GSK Investigational Site
Anniston, Alabama, 36207, United States
GSK Investigational Site
Birmingham, Alabama, 35205, United States
GSK Investigational Site
Birmingham, Alabama, 35215, United States
GSK Investigational Site
Huntsville, Alabama, 35801, United States
GSK Investigational Site
Montgomery, Alabama, 36106, United States
GSK Investigational Site
Montgomery, Alabama, 36111, United States
GSK Investigational Site
Glendale, Arizona, 85308, United States
GSK Investigational Site
Scottsdale, Arizona, 85251, United States
GSK Investigational Site
Tucson, Arizona, 85704, United States
GSK Investigational Site
Tucson, Arizona, 85719, United States
GSK Investigational Site
Anaheim, California, 92801, United States
GSK Investigational Site
Palm Desert, California, 92260, United States
GSK Investigational Site
San Diego, California, 92103-6204, United States
GSK Investigational Site
San Diego, California, 92108, United States
GSK Investigational Site
San Diego, California, 92128, United States
GSK Investigational Site
Santa Monica, California, 90048, United States
GSK Investigational Site
Upland, California, 91786, United States
GSK Investigational Site
Colorado Springs, Colorado, 80909, United States
GSK Investigational Site
Bridgeport, Connecticut, 06606, United States
GSK Investigational Site
Danbury, Connecticut, 06810, United States
GSK Investigational Site
Hamden, Connecticut, 06518, United States
GSK Investigational Site
Trumbull, Connecticut, 06611, United States
GSK Investigational Site
Aventura, Florida, 33180, United States
GSK Investigational Site
Daytona Beach, Florida, 32114, United States
GSK Investigational Site
DeLand, Florida, 32720, United States
GSK Investigational Site
Dunedin, Florida, 34698, United States
GSK Investigational Site
Largo, Florida, 33773, United States
GSK Investigational Site
Miami, Florida, 33156, United States
GSK Investigational Site
Miami, Florida, 33173, United States
GSK Investigational Site
Ocala, Florida, 34474, United States
GSK Investigational Site
Orlando, Florida, 32804, United States
GSK Investigational Site
Orlando, Florida, 32806, United States
GSK Investigational Site
Palm Harbor, Florida, 34684, United States
GSK Investigational Site
Port Orange, Florida, 32127, United States
GSK Investigational Site
Stuart, Florida, 34996, United States
GSK Investigational Site
Tampa, Florida, 33614, United States
GSK Investigational Site
Trinity, Florida, 34655, United States
GSK Investigational Site
West Palm Beach, Florida, 33409, United States
GSK Investigational Site
Zephyrhills, Florida, 33540, United States
GSK Investigational Site
Atlanta, Georgia, 30342, United States
GSK Investigational Site
Gainsville, Georgia, 30501, United States
GSK Investigational Site
Roswell, Georgia, 30075, United States
GSK Investigational Site
Woodstock, Georgia, 30189, United States
GSK Investigational Site
Idaho Falls, Idaho, 83401, United States
GSK Investigational Site
Evanston, Illinois, 60201, United States
GSK Investigational Site
Morton Grove, Illinois, 60053, United States
GSK Investigational Site
Springfield, Illinois, 62704, United States
GSK Investigational Site
Evansville, Indiana, 47714, United States
GSK Investigational Site
Indianapolis, Indiana, 46202, United States
GSK Investigational Site
Indianapolis, Indiana, 46227, United States
GSK Investigational Site
Prairie Village, Kansas, 66206, United States
GSK Investigational Site
Wichita, Kansas, 67207, United States
GSK Investigational Site
Louisville, Kentucky, 40202, United States
GSK Investigational Site
Louisville, Kentucky, 40207, United States
GSK Investigational Site
Louisville, Kentucky, 40213, United States
GSK Investigational Site
New Orleans, Louisiana, 70115, United States
GSK Investigational Site
Slidell, Louisiana, 70458, United States
GSK Investigational Site
Wheaton, Maryland, 20902, United States
GSK Investigational Site
Fall River, Massachusetts, 02720, United States
GSK Investigational Site
Springfield, Massachusetts, 01107, United States
GSK Investigational Site
Kalamazoo, Michigan, 49048, United States
GSK Investigational Site
Lansing, Michigan, 48910, United States
GSK Investigational Site
St Louis, Missouri, 63117, United States
GSK Investigational Site
St Louis, Missouri, 63141, United States
GSK Investigational Site
Las Vegas, Nevada, 89103, United States
GSK Investigational Site
Las Vegas, Nevada, 89106, United States
GSK Investigational Site
Las Vegas, Nevada, 89128, United States
GSK Investigational Site
Reno, Nevada, 89502, United States
GSK Investigational Site
Dover, New Hampshire, 03820, United States
GSK Investigational Site
Berlin, New Jersey, 08009, United States
GSK Investigational Site
Mercerville, New Jersey, 08619, United States
GSK Investigational Site
Johnson City, New York, 13790, United States
GSK Investigational Site
Kingston, New York, 12401, United States
GSK Investigational Site
New York, New York, 10024, United States
GSK Investigational Site
North Massapequa, New York, 11758, United States
GSK Investigational Site
Rochester, New York, 14618, United States
GSK Investigational Site
Charlotte, North Carolina, 28210, United States
GSK Investigational Site
Gastonia, North Carolina, 28054, United States
GSK Investigational Site
Hickory, North Carolina, 28601, United States
GSK Investigational Site
Statesville, North Carolina, 28625, United States
GSK Investigational Site
Cleveland, Ohio, 44130, United States
GSK Investigational Site
Columbus, Ohio, 43210, United States
GSK Investigational Site
Concinnati, Ohio, 45219, United States
GSK Investigational Site
Mayfield Village, Ohio, 44143, United States
GSK Investigational Site
Oklahoma City, Oklahoma, 73112, United States
GSK Investigational Site
Tulsa, Oklahoma, 74104, United States
GSK Investigational Site
Tulsa, Oklahoma, 74135, United States
GSK Investigational Site
Medford, Oregon, 97504, United States
GSK Investigational Site
Duncansville, Pennsylvania, 16635, United States
GSK Investigational Site
Philadelphia, Pennsylvania, 19118, United States
GSK Investigational Site
Philadelphia, Pennsylvania, 19140, United States
GSK Investigational Site
West Reading, Pennsylvania, 19611, United States
GSK Investigational Site
Charleston, South Carolina, 29406, United States
GSK Investigational Site
Charleston, South Carolina, 29407, United States
GSK Investigational Site
Greer, South Carolina, 29651, United States
GSK Investigational Site
Hampton, South Carolina, 29924, United States
GSK Investigational Site
Murrells Inlet, South Carolina, 29576, United States
GSK Investigational Site
Memphis, Tennessee, 38119, United States
GSK Investigational Site
Austin, Texas, 78705, United States
GSK Investigational Site
Dallas, Texas, 75231, United States
GSK Investigational Site
San Antonio, Texas, 78229, United States
GSK Investigational Site
San Antonio, Texas, 78232, United States
GSK Investigational Site
Everett, Washington, 98201, United States
GSK Investigational Site
Vancouver, Washington, 98664, United States
GSK Investigational Site
Racine, Wisconsin, 53404, United States
GSK Investigational Site
Córdoba, Córdoba Province, 5000, Argentina
GSK Investigational Site
Córdoba, Córdoba Province, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, 2000, Argentina
GSK Investigational Site
Buenos Aires, 1013, Argentina
GSK Investigational Site
Buenos Aires, 1427, Argentina
GSK Investigational Site
Buenos Aires, C1121ABE, Argentina
GSK Investigational Site
Buenos Aires, C1128AAF, Argentina
GSK Investigational Site
Buenos Aires, C1426BOR, Argentina
GSK Investigational Site
Córdoba, 5000, Argentina
GSK Investigational Site
Quilmes, 1878, Argentina
GSK Investigational Site
San Juan, 5400, Argentina
GSK Investigational Site
San Miguel de Tucumán, 4000, Argentina
GSK Investigational Site
Vienna, A-1021, Austria
GSK Investigational Site
Vienna, A-1060, Austria
GSK Investigational Site
Vienna, A-1090, Austria
GSK Investigational Site
Vienna, A-1100, Austria
GSK Investigational Site
Antwerp, 2020, Belgium
GSK Investigational Site
Diepenbeek, 3590, Belgium
GSK Investigational Site
Lommel, 3920, Belgium
GSK Investigational Site
Mons, 7000, Belgium
GSK Investigational Site
Pleven, 5800, Bulgaria
GSK Investigational Site
Sofia, 1233, Bulgaria
GSK Investigational Site
Sofia, 1431/1000, Bulgaria
GSK Investigational Site
Sofia, 1431, Bulgaria
GSK Investigational Site
Varna, 9010, Bulgaria
GSK Investigational Site
Edmonton, Alberta, T5K 2A2, Canada
GSK Investigational Site
Penticton, British Columbia, V2A 3G8, Canada
GSK Investigational Site
Victoria, British Columbia, V8P 5P6, Canada
GSK Investigational Site
Winnipeg, Manitoba, R3A 1M3, Canada
GSK Investigational Site
St. John's, Newfoundland and Labrador, A1B 3E1, Canada
GSK Investigational Site
Kitchener, Ontario, N2M 5N6, Canada
GSK Investigational Site
Mississauga, Ontario, L5M 2V8, Canada
GSK Investigational Site
Toronto, Ontario, M4N 3M5, Canada
GSK Investigational Site
Toronto, Ontario, M5T 2S8, Canada
GSK Investigational Site
Toronto, Ontario, M9W 4L6, Canada
GSK Investigational Site
Windsor, Ontario, N8X 5A6, Canada
GSK Investigational Site
Montreal, Quebec, H3T 1E2, Canada
GSK Investigational Site
Montreal, Quebec, H3Z 2Z3, Canada
GSK Investigational Site
Saint-Jérôme, Quebec, J7Z 5T3, Canada
GSK Investigational Site
Sainte-Foy, Quebec, G1W 4R4, Canada
GSK Investigational Site
Trois-Rivières, Quebec, G8Z 1Y2, Canada
GSK Investigational Site
Saskatoon, Saskatchewan, S7N 0W8, Canada
GSK Investigational Site
Viña del Mar, Región de Valparaíso, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, 8380456, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, Chile
GSK Investigational Site
San José, Costa Rica
GSK Investigational Site
Aalborg, 9000, Denmark
GSK Investigational Site
Ishøj, 2635, Denmark
GSK Investigational Site
Odense C, 5000, Denmark
GSK Investigational Site
Vejle, 7100, Denmark
GSK Investigational Site
Helsinki, 00100, Finland
GSK Investigational Site
Hyvinkää, 05800, Finland
GSK Investigational Site
Kuopio, 70100, Finland
GSK Investigational Site
Angers, 49100, France
GSK Investigational Site
Cahors, 46005, France
GSK Investigational Site
Chilly-Mazarin, 91380, France
GSK Investigational Site
Corbeil-Essonnes, 91106, France
GSK Investigational Site
Grenoble, 38042, France
GSK Investigational Site
Lyon, 69002, France
GSK Investigational Site
Paris, 75571, France
GSK Investigational Site
Toulouse, 31300, France
GSK Investigational Site
Tours, 37000, France
GSK Investigational Site
Baden-Baden, Baden-Wurttemberg, 76530, Germany
GSK Investigational Site
Deggingen, Baden-Wurttemberg, 73326, Germany
GSK Investigational Site
Freiburg im Breisgau, Baden-Wurttemberg, 79098, Germany
GSK Investigational Site
Kippenheim, Baden-Wurttemberg, 77971, Germany
GSK Investigational Site
Stuttgart, Baden-Wurttemberg, 66111, Germany
GSK Investigational Site
Stuttgart, Baden-Wurttemberg, 70469, Germany
GSK Investigational Site
Weinheim, Baden-Wurttemberg, 69469, Germany
GSK Investigational Site
Bayreuth, Bavaria, 95445, Germany
GSK Investigational Site
Erlangen, Bavaria, 91054, Germany
GSK Investigational Site
Munich, Bavaria, 80333, Germany
GSK Investigational Site
Munich, Bavaria, 80339, Germany
GSK Investigational Site
Nuremberg, Bavaria, 90402, Germany
GSK Investigational Site
Passau, Bavaria, 94032, Germany
GSK Investigational Site
Hamburg, Hamburg, 20249, Germany
GSK Investigational Site
Hamburg, Hamburg, 22143, Germany
GSK Investigational Site
Hamburg, Hamburg, 22415, Germany
GSK Investigational Site
Hüttenberg, Hesse, 35625, Germany
GSK Investigational Site
Wiesbaden, Hesse, 65185, Germany
GSK Investigational Site
Einbeck, Lower Saxony, 37574, Germany
GSK Investigational Site
Hanover, Lower Saxony, 30519, Germany
GSK Investigational Site
Hildesheim, Lower Saxony, 31134, Germany
GSK Investigational Site
Schwerin, Mecklenburg-Vorpommern, 19055, Germany
GSK Investigational Site
Aachen, North Rhine-Westphalia, 52064, Germany
GSK Investigational Site
Beckum, North Rhine-Westphalia, 59269, Germany
GSK Investigational Site
Bochum, North Rhine-Westphalia, 44787, Germany
GSK Investigational Site
Cologne, North Rhine-Westphalia, 51069, Germany
GSK Investigational Site
Essen, North Rhine-Westphalia, 45326, Germany
GSK Investigational Site
Goch, North Rhine-Westphalia, 47574, Germany
GSK Investigational Site
Hattingen, North Rhine-Westphalia, 45525, Germany
GSK Investigational Site
Münster, North Rhine-Westphalia, 48155, Germany
GSK Investigational Site
Witten, North Rhine-Westphalia, 58455, Germany
GSK Investigational Site
Rhaunen, Rhineland-Palatinate, 55624, Germany
GSK Investigational Site
Saarbrücken, Saarland, 66111, Germany
GSK Investigational Site
Chemnitz, Saxony, 09111, Germany
GSK Investigational Site
Delitzsch, Saxony, 04509, Germany
GSK Investigational Site
Dresden, Saxony, 01067, Germany
GSK Investigational Site
Freital, Saxony, 01705, Germany
GSK Investigational Site
Görlitz, Saxony, 02826, Germany
GSK Investigational Site
Leipzig, Saxony, 04107, Germany
GSK Investigational Site
Leipzig, Saxony, 04229, Germany
GSK Investigational Site
Schmiedeberg, Saxony, 01762, Germany
GSK Investigational Site
Wolmirstedt, Saxony-Anhalt, 39326, Germany
GSK Investigational Site
Elmshorn, Schleswig-Holstein, 25335, Germany
GSK Investigational Site
Lübeck, Schleswig-Holstein, 23538, Germany
GSK Investigational Site
Pinneberg, Schleswig-Holstein, 25421, Germany
GSK Investigational Site
Berlin, State of Berlin, 10777, Germany
GSK Investigational Site
Berlin, State of Berlin, 12247, Germany
GSK Investigational Site
Berlin, State of Berlin, 13125, Germany
GSK Investigational Site
Berlin, State of Berlin, 14057, Germany
GSK Investigational Site
Berlin, State of Berlin, 14109, Germany
GSK Investigational Site
Kavala, 65403, Greece
GSK Investigational Site
Thessaloniki, 546 36, Greece
GSK Investigational Site
Thessaloniki, 54642, Greece
GSK Investigational Site
Thessaloniki, 564 29, Greece
GSK Investigational Site
Budapest, 1023, Hungary
GSK Investigational Site
Budapest, 1238, Hungary
GSK Investigational Site
Budapest, Hungary
GSK Investigational Site
Győr, 9024, Hungary
GSK Investigational Site
Bangalore, 560 017, India
GSK Investigational Site
Bangalore, 560 054, India
GSK Investigational Site
Bangalore, 560034, India
GSK Investigational Site
Chennai, 600003, India
GSK Investigational Site
Hyderabad, 500 004, India
GSK Investigational Site
Hyderabad, Andhra Pradesh, 500482, India
GSK Investigational Site
New Delhi, India
GSK Investigational Site
Pune, 411 001, India
GSK Investigational Site
Dublin, 9, Ireland
GSK Investigational Site
Waterford, Ireland
GSK Investigational Site
Pescara, Abruzzo, 65100, Italy
GSK Investigational Site
Benevento, Campania, 82100, Italy
GSK Investigational Site
Telese Terme (BN), Campania, 82100, Italy
GSK Investigational Site
Arenzano (GE), Liguria, 16011, Italy
GSK Investigational Site
Genoa, Liguria, 16148, Italy
GSK Investigational Site
Rozzano (MI), Lombardy, 20089, Italy
GSK Investigational Site
Pisa, Tuscany, 56126, Italy
GSK Investigational Site
Prato, Tuscany, 59100, Italy
GSK Investigational Site
Terni, Umbria, 05100, Italy
GSK Investigational Site
Montebelluna (TV), Veneto, 31044, Italy
GSK Investigational Site
Liepāja, LV3400, Latvia
GSK Investigational Site
Riga, LV 1002, Latvia
GSK Investigational Site
Riga, LV1079, Latvia
GSK Investigational Site
Valmiera, Latvia
GSK Investigational Site
Guadalajara, Jalisco, 44280, Mexico
GSK Investigational Site
Guadalajara, Jalisco, 44340, Mexico
GSK Investigational Site
Monterrey, Nuevo León, 64020, Mexico
GSK Investigational Site
Mexico City, 06720, Mexico
GSK Investigational Site
México, 06700, Mexico
GSK Investigational Site
México, Mexico
GSK Investigational Site
Etten-Leur, 4872 LA, Netherlands
GSK Investigational Site
Gouda, 2803 HH, Netherlands
GSK Investigational Site
Heerlen, 6416 EG, Netherlands
GSK Investigational Site
Nijmegen, 6525 GA, Netherlands
GSK Investigational Site
The Hague, 2597 AX, Netherlands
GSK Investigational Site
Zwolle, 8011 JW, Netherlands
GSK Investigational Site
Auckland, 1309, New Zealand
GSK Investigational Site
Auckland, 1701, New Zealand
GSK Investigational Site
Christchurch, 8001, New Zealand
GSK Investigational Site
Lower Hutt, 6009, New Zealand
GSK Investigational Site
Rotorua, 3201, New Zealand
GSK Investigational Site
Harstad, 9480, Norway
GSK Investigational Site
Levanger, 7600, Norway
GSK Investigational Site
Lillehammer, 2609, Norway
GSK Investigational Site
Skien, 3722, Norway
GSK Investigational Site
Tønsberg, N-3117, Norway
GSK Investigational Site
Lima, Lima Province, Lima 27, Peru
GSK Investigational Site
Callao, Callao 2, Peru
GSK Investigational Site
Lima, Lima 27, Peru
GSK Investigational Site
Lima, Lima 39, Peru
GSK Investigational Site
Manila, 1000, Philippines
GSK Investigational Site
Manila, 1003, Philippines
GSK Investigational Site
Grudziądz, 86-300, Poland
GSK Investigational Site
Poznan, 61-544, Poland
GSK Investigational Site
Warsaw, 02-341, Poland
GSK Investigational Site
Wroclaw, 50-044, Poland
GSK Investigational Site
Wroclaw, 50-088, Poland
GSK Investigational Site
Caguas, Puerto Rico, 00726, Puerto Rico
GSK Investigational Site
Brasov, 500366, Romania
GSK Investigational Site
Bucharest, 11172, Romania
GSK Investigational Site
Bucharest, 20983, Romania
GSK Investigational Site
Bucharest, Romania
GSK Investigational Site
Moscow, 115522, Russia
GSK Investigational Site
Moscow, 119049, Russia
GSK Investigational Site
Moscow, 129327, Russia
GSK Investigational Site
Moscow, Russia
GSK Investigational Site
Ryazan, 390026, Russia
GSK Investigational Site
Saint Petersburg, Russia
GSK Investigational Site
Saratov, 410053, Russia
GSK Investigational Site
Tula, 300053, Russia
GSK Investigational Site
Yaroslavl, 150003, Russia
GSK Investigational Site
Yaroslavl, 150062, Russia
GSK Investigational Site
Yekaterinburg, 620102, Russia
GSK Investigational Site
Korsten, Eastern Cape, 6020, South Africa
GSK Investigational Site
Boksburg, Gauteng, South Africa
GSK Investigational Site
Muckleneuk, Gauteng, 0001, South Africa
GSK Investigational Site
Parktown, Gauteng, 2193, South Africa
GSK Investigational Site
Cape Town, 7525, South Africa
GSK Investigational Site
Durban, 4001, South Africa
GSK Investigational Site
Erasmus Kloof, Pretoria, 0048, South Africa
GSK Investigational Site
Kempton Park, 1619, South Africa
GSK Investigational Site
Observatory, 7925, South Africa
GSK Investigational Site
Pinetown, 7405, South Africa
GSK Investigational Site
Anyang-si, 431-070, South Korea
GSK Investigational Site
Daegu, 705-718, South Korea
GSK Investigational Site
Seoul, 110-744, South Korea
GSK Investigational Site
Seoul, 120-752, South Korea
GSK Investigational Site
Seoul, 138-736, South Korea
GSK Investigational Site
Seoul, South Korea
GSK Investigational Site
A Coruña, 15006, Spain
GSK Investigational Site
Baracaldo/Vizcaya, 48903, Spain
GSK Investigational Site
Barcelona, 08003, Spain
GSK Investigational Site
Barcelona, 08025, Spain
GSK Investigational Site
Barcelona, 08035, Spain
GSK Investigational Site
Córdoba, 14004, Spain
GSK Investigational Site
Granada, 18014, Spain
GSK Investigational Site
Guadalajara, 19002, Spain
GSK Investigational Site
Mérida (Badajoz), 06800, Spain
GSK Investigational Site
Oviedo, 33006, Spain
GSK Investigational Site
Pamplona, 31008, Spain
GSK Investigational Site
San Sebastián, 20014, Spain
GSK Investigational Site
Santiago de Compostela, 15706, Spain
GSK Investigational Site
Seville, 41071, Spain
GSK Investigational Site
Valencia, 46017, Spain
GSK Investigational Site
Villajoyosa, 3570, Spain
GSK Investigational Site
Kharkiv, 61002, Ukraine
GSK Investigational Site
Kharkiv, 61039, Ukraine
GSK Investigational Site
Kiev, Ukraine
GSK Investigational Site
Kyiv, 03680, Ukraine
GSK Investigational Site
Lviv, 79010, Ukraine
GSK Investigational Site
Truro, Cornwall, TR1 3LJ, United Kingdom
GSK Investigational Site
St Albans, Hertfordshire, AL3 5PN, United Kingdom
GSK Investigational Site
Manchester, Lancashire, M13 9WL, United Kingdom
GSK Investigational Site
Metropolitan Borough of Wirral, Merseyside, CH49 9PE, United Kingdom
GSK Investigational Site
Ashford, Middlesex, TW15 3AA, United Kingdom
GSK Investigational Site
Northampton, Northamptonshire, NN1 5BD, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2005
First Posted
June 8, 2005
Study Start
June 1, 2005
Primary Completion
September 1, 2006
Study Completion
September 1, 2006
Last Updated
March 14, 2017
Record last verified: 2017-03